X4 Pharmaceuticals Alternatives & Competitors
12 companies similar to X4 Pharmaceuticals — Enabling a better future for people with rare immune disorders
Companies similar to X4 Pharmaceuticals
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
South San Francisco, Unit...
Soligenix, Inc.
We are a late-stage biopharmaceutical company focused on developing & commercializing prod...
Princeton, United States
Montis Biosciences
Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...
Belgium
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Redwood City, United Stat...
Track all X4 Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Allena Pharmaceuticals, Inc.
Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders
Newton, United States
Cyxone
Life-changing treatments for disorders of the immune system
Malmo, Sweden
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Wize Pharma
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment o...
Hod Hasharon, Israel
Alzprotect SAS
Therapeutic Solutions for Neurodegeneration
Loos, France
Soleno Therapeutics, Inc.
Inspired by patients and families around the world, we are advancing much needed therapies...
Redwood City, United Stat...
Eloxx Pharmaceuticals
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...
Watertown, United States
San Diego, United States
About X4 Pharmaceuticals
X4 Pharmaceuticals, with the slogan "Enabling a better future for people with rare immune disorders," is a commercial-stage clinical biopharmaceutical company focused on improving the lives of individuals with rare immune system diseases. The company's flagship product, mavorixafor, has obtained FDA approval under the...
Biopharmaceutical Company, Clinical Trials, Rare Diseases, Immunodeficiency, Neutropenic Disorders, Mavorixafor Therapy, CXCR4 Antagonist, WHIM Syndrome, Phase 3 Clinical Trial, Regulatory Approval, Public Company, Drug Development, Immune System Disorders, Patient Advocacy
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches X4 Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at X4 Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
